Notes from the Alternative and Special Situations Value Investing Panel featuring Verdad Capital's Brian Chingono, CarVal Investors' William Schatz, Bluemountain Capital's Omar Vaishnavi, and Wincrest Capital's Barbara Ann Bernard from the 2019 Ben Graham VI Annual Conference, which took place on Wednesday, June 19. Abbott Laboratories (NYSE:ABT) Abbott Laboratories (NYSE:ABT) is scheduled to release its Q2 2013 earnings results before the market open on Wednesday, July 17.